ES2055010T3 - Vacuna adecuada para la profilaxis y el control, respectivamente, de la enfermedad del ganado porcino causada por haemophilus pleuropneumoniae y su metodo de obtencion. - Google Patents

Vacuna adecuada para la profilaxis y el control, respectivamente, de la enfermedad del ganado porcino causada por haemophilus pleuropneumoniae y su metodo de obtencion.

Info

Publication number
ES2055010T3
ES2055010T3 ES89202080T ES89202080T ES2055010T3 ES 2055010 T3 ES2055010 T3 ES 2055010T3 ES 89202080 T ES89202080 T ES 89202080T ES 89202080 T ES89202080 T ES 89202080T ES 2055010 T3 ES2055010 T3 ES 2055010T3
Authority
ES
Spain
Prior art keywords
pleuroneumoniae
control
prophylaxis
disease
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89202080T
Other languages
English (en)
Inventor
Leengoed Leonardus Adrianu Van
Elbarte Margriet Kamp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19852751&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2055010(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Application granted granted Critical
Publication of ES2055010T3 publication Critical patent/ES2055010T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION SE REFIERE A UNA VACUNA ADECUADA PARA LA PROFILASIS Y CONTROL, RESPECTIVAMENTE, DE HAEMOPHILUS PLEURONEUMONIAE, CON VENTAJA SOBRE TODOS LOS SEROTIPOS DE H. PLEURONEUMONIAE, VACUNA QUE SE BASA EN UN CONTENIDO EFICAZ DE UNA MEZCLA DE MATERIAL PROTEINICO EXTRACELULAR DERIVADO DEL MEDIO DE CULTIVO DE CEPAS DE POR LO MENOS DOS SEROTIPOS DIFERENTES DE H. PLEURONEUMONIAE, PREFERIBLEMENTE DERIVADO DEL MEDIO DE CULTIVO DE POR LO MENOS UNS CEPA DE H. PLEURONEUMONIAE ELEGIDA DEL GRUPO DE SEROTIPOS 1, 5, 6, 9 Y 11, POR UNA PARTE, Y EL MEDIO DE CULTIVO DE POR LO MENOS UNA CEPA DE H. PLEURONEUMONIAE DEL GRUPO DE SEROTIUPOS 2, 3, 4 Y 8, POR OTRA.
ES89202080T 1988-08-12 1989-08-11 Vacuna adecuada para la profilaxis y el control, respectivamente, de la enfermedad del ganado porcino causada por haemophilus pleuropneumoniae y su metodo de obtencion. Expired - Lifetime ES2055010T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8802007A NL8802007A (nl) 1988-08-12 1988-08-12 Vaccin, geschikt voor de profylaxe respectievelijk de bestrijding van de door haemophilus pleuropneumoniae teweeggebrachte ziekte bij varkens alsmede werkwijze voor het winnen van extracellulair eiwitachtig materiaal van haemophilus pleuropneumonie, geschikt voor toepassing in dergelijke vaccins.

Publications (1)

Publication Number Publication Date
ES2055010T3 true ES2055010T3 (es) 1994-08-16

Family

ID=19852751

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89202080T Expired - Lifetime ES2055010T3 (es) 1988-08-12 1989-08-11 Vacuna adecuada para la profilaxis y el control, respectivamente, de la enfermedad del ganado porcino causada por haemophilus pleuropneumoniae y su metodo de obtencion.

Country Status (10)

Country Link
US (1) US5254340A (es)
EP (1) EP0354628B1 (es)
JP (1) JPH0725697B2 (es)
AR (1) AR243385A1 (es)
AT (1) ATE103816T1 (es)
CA (1) CA1334388C (es)
DE (1) DE68914362T2 (es)
DK (1) DK394889A (es)
ES (1) ES2055010T3 (es)
NL (1) NL8802007A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641653A (en) * 1989-10-31 1997-06-24 The Texas A&M University System DNA encoding Actinobacillus pleuropneumoniae hemolysin
DE69110082T2 (de) * 1990-04-20 1995-11-09 Akzo Nobel Nv Untereinheit-Impfstoff gegen Actinobacillus Pleuropneumoniae.
KR100258772B1 (ko) * 1990-12-19 2000-08-01 피터씨.리챠드슨 돼지의 흉막폐염 백신 조성물
US5994525A (en) * 1991-06-28 1999-11-30 Kamp; Elbarte Margriet Nucleic acid encoding Actinobacillus pleuropneumoniae cytolytic proteins
JPH05262666A (ja) * 1992-03-24 1993-10-12 Biseibutsu Kagaku Kenkyusho:Kk 豚胸膜肺炎多価ワクチン
US7008790B1 (en) * 1993-08-12 2006-03-07 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US5728385A (en) * 1993-08-12 1998-03-17 Classen Immunotherapies, Inc. Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
US5925354A (en) 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK138379A (da) * 1979-04-04 1980-10-05 Nordisk Droge & Kemikalie Vaccine imod pleuropneumonia (ondartet lungesyge) hos svin dens anvendelse samt fremgangsmaade og substat til dyrkning specielt aerob fermentering af mikroorganismen haemophilus pleuropneumoniae

Also Published As

Publication number Publication date
JPH02152930A (ja) 1990-06-12
DE68914362D1 (de) 1994-05-11
EP0354628B1 (en) 1994-04-06
NL8802007A (nl) 1990-03-01
CA1334388C (en) 1995-02-14
DK394889D0 (da) 1989-08-11
JPH0725697B2 (ja) 1995-03-22
DE68914362T2 (de) 1994-10-20
EP0354628A1 (en) 1990-02-14
ATE103816T1 (de) 1994-04-15
DK394889A (da) 1990-02-13
US5254340A (en) 1993-10-19
AR243385A1 (es) 1993-08-31

Similar Documents

Publication Publication Date Title
SE8504254D0 (sv) Antibiotiska foreningar och deras framstellning
MX9303992A (es) Mutantes de eliminacion como vacunas para el colera.
ES2055010T3 (es) Vacuna adecuada para la profilaxis y el control, respectivamente, de la enfermedad del ganado porcino causada por haemophilus pleuropneumoniae y su metodo de obtencion.
YU76695A (sh) Formulacije mastila za štampače sa mlaznicom koje sadrže modifikovane ugljenične proizvode
DE3868127D1 (de) F-serien-prostaglandine.
PT90030A (pt) Processo para a preparacao de liofilisado de ifosfamida e mesna
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
ES522637A0 (es) Procedimiento para la preparacion de nuevas sustancias ws 6049.
PT93324A (pt) Processo para a preparacao de fosfatos de {3-alcano-sulfinil- e sulfonil-2-meto-ximetil-propil}-(2-tirmetilamonio-etilo) cujo grupo alcano possui 16 a 18 atomos de carbono, e de composicoes farmaceuticas que os contem
FR2633518B1 (fr) Procede de stabilisation des vaccins et associations de vaccins a virus attenues conserves sous forme lyophilisee, et compositions obtenues
ES2025663T3 (es) Composiciones inoculantes para plantas.
ES505256A0 (es) Un procedimiento para la preparacion del nuevo antibiotico bmo162-af2, obtenido mediante el cultivo de una cepa perte- neciente al genero bacillus.
ES506116A0 (es) Procedimiento para la obtencion de isomaltulosa a partir de sacarosa
PT72175A (fr) Procede de preparation de derives de benzofuranne
NO873860D0 (no) Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
KR900007330A (ko) Drechslera spp. 또는 이것의 대사산물을 함유하는 잡초 방제조성물 및 Drechslera spp. 또는 이것의 대사산물을 사용하는 잡초방제 방법
DE10299020I2 (de) Salmonella-Lebendimpfstoff
FI853832L (fi) Sammansaettning som doedar eller haemmar tillvaexten av mikroorganismer och anvaendningen daerav.
ATE123625T1 (de) Herstellung von erhöhten biokontrollwirkstoffen.
BR8805462A (pt) Processo aperfeicoado para a preparacao de um ciclobutareno
ES2072865T3 (es) Cepa bacteriana.
ES546915A0 (es) Procedimiento para preparar nuevos antibioticos policiclicos por fermentacion de una cepa de actinomadura melliaura.
KR910000106A (ko) 발모촉진제
FR2099696A1 (en) Acidic glutaraldehyde soln for sterilising - contaminated objects
DK0420743T3 (da) Vaccine til beskyttelse mod svinehæmophilose

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 354628

Country of ref document: ES